Microfluidic Devices Market in the Healthcare Industry to 2015

2013-01-22
Published : Jan-2013

TechNavio”s analysts forecast the Global Microfluidic Devices market in the Healthcare industry to grow at a CAGR of 26.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing use of microfluidic devices in proteomics and genomics. The Global Microfluidic Devices market in the Healthcare industry has also been witnessing the trend of the increasing use of microfluidic devices in drug discovery. However, the intense competition among vendors could pose a challenge to the growth of this market.

TechNavio”s report, the Global Microfluidic Devices Market in the Healthcare Industry 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Monoclonal Antibodies market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Fluidigm Corp., RainDance Technologies Inc., Agilent Technologies Inc., and Dolomite Centre Ltd.

The other vendors mentioned in the report are Micronit Microfluidics BV, Illumina Inc., MicruX Technologies Inc., Abbott Laboratories, Boehringer Ingelheim GmbH, BioFluidix GmbH, Abaxis Inc., Advion Biosciences Inc., Caliper Life Sciences Inc., Cepheid Inc., Danaher Corp., Eksigent Technologies Inc., GE Novasensor Inc., Illumina Inc., Johnson and Johnson, Konica Minolta Holdings Inc., Microfluidic Systems Inc., Life Technologies Corp., Philips Healthcare, Roche Diagnostics, Shimadzu Biotech, and Siemens Healthcare.

Key questions answered in this report:
What will the market size be in 2015 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.

TechNavio”s research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.

Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=212064.

Table of Contents

01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Product Offerings
04. Market Landscape
Market Size and Forecast
04.1 Market Segmentation by Application
04.2 Five Forces Analysis
05. Vendor Landscape
06. Buying Criteria
07. Market Growth Drivers
08. Drivers and Their Impact
09. Market Challenges
10. Impact of Drivers and Challenges
11. Market Trends
12. Key Vendor Analysis
12.1 Fluidigm Corp.
Business Overview
Key Information
SWOT Analysis
12.2 RainDance Technologies Inc.
Business Overview
Key Information
SWOT Analysis
12.3 Agilent Technologies Inc.
Business Overview
Key Information
SWOT Analysis
12.4 Dolomite Centre Ltd.
Business Overview
Key Information
SWOT Analysis
13. Other Reports in this Series

List of Exhibits:
Exhibit 1: Global Microfluidic Devices Market in the Healthcare Industry 2011-2015 (US$ million)
Exhibit 2: Global Microfluidic Devices Market in the Healthcare Industry Segmentation by Application 2011
Exhibit 3: Global Microfluidic Devices Market in the Healthcare Industry Segmentation 2011-2015 (in percent)
Exhibit 4: Global Microfluidic Devices Market in the Healthcare Industry Segmentation 2011-2015 (in US$ million)
Exhibit 5: Global Microfluidic Devices Market in the Healthcare Industry by Vendor Segmentation (by revenue) 2011

Contact sales@reportsandreports.com for further information.

Filed in: Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – New Zealand

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in New Zealand. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of New Zealand. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, a......
$1995

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Belgium

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Belgium Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Belgium". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Belgium. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Belgium. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house anal......
$1995

Neurofibromatoses Global Clinical Trials Review, H1, 2018

Neurofibromatoses Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Neurofibromatoses Global Clinical Trials Review, H1, 2018" provides an overview of Neurofibromatoses clinical trials scenario. This report provides top line data relating to the clinical trials on Neurofibromatoses. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials da......
$2500

Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2018

Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2018" provides an overview of Non Alcoholic Fatty Liver Disease (NAFLD) clinical trials scenario. This report provides top line data relating to the clinical trials on Non Alcoholic Fatty Liver Disease (NAFLD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial ......
$2500

Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2018

Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2018" provides an overview of Neonatal Respiratory Distress Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Neonatal Respiratory Distress Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are ......
$2500

Obsessive-Compulsive Disorder Global Clinical Trials Review, H1, 2018

Obsessive-Compulsive Disorder Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Obsessive-Compulsive Disorder Global Clinical Trials Review, H1, 2018" provides an overview of Obsessive-Compulsive Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Obsessive-Compulsive Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprie......
$2500

Neurofibromatoses Type I (Von Recklinghausen’s Disease) Global Clinical Trials Review, H1, 2018

Neurofibromatoses Type I (Von Recklinghausen's Disease) Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Neurofibromatoses Type I (Von Recklinghausen's Disease) Global Clinical Trials Review, H1, 2018" provides an overview of Neurofibromatoses Type I (Von Recklinghausen's Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Neurofibromatoses Type I (Von Recklinghausen's Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based ......
$2500

Non Malignant pain Global Clinical Trials Review, H1, 2018

Non Malignant pain Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Non Malignant pain Global Clinical Trials Review, H1, 2018" provides an overview of Non Malignant pain clinical trials scenario. This report provides top line data relating to the clinical trials on Non Malignant pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Neonatal Seizures Global Clinical Trials Review, H1, 2018

Neonatal Seizures Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Neonatal Seizures Global Clinical Trials Review, H1, 2018" provides an overview of Neonatal Seizures clinical trials scenario. This report provides top line data relating to the clinical trials on Neonatal Seizures. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials da......
$2500

Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2018

Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, "Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2018" provides an overview of Obstructive Pulmonary Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Obstructive Pulmonary Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprie......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy